PYPB Stock Overview
Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
IXICO plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.15 |
| 52 Week High | UK£0.16 |
| 52 Week Low | UK£0.071 |
| Beta | 0.75 |
| 11 Month Change | 38.68% |
| 3 Month Change | 33.64% |
| 1 Year Change | -7.55% |
| 33 Year Change | -76.10% |
| 5 Year Change | -82.07% |
| Change since IPO | -78.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| PYPB | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 47.0% | 3.9% | 0.8% |
| 1Y | -7.5% | 5.4% | 9.1% |
Return vs Industry: PYPB underperformed the German Life Sciences industry which returned 3.6% over the past year.
Return vs Market: PYPB underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| PYPB volatility | |
|---|---|
| PYPB Average Weekly Movement | 8.0% |
| Life Sciences Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PYPB's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: PYPB's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 89 | Bram Goorden | ixico.com |
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
IXICO plc Fundamentals Summary
| PYPB fundamental statistics | |
|---|---|
| Market cap | €13.87m |
| Earnings (TTM) | -€2.23m |
| Revenue (TTM) | €7.18m |
1.9x
P/S Ratio-6.2x
P/E RatioIs PYPB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PYPB income statement (TTM) | |
|---|---|
| Revenue | UK£6.00m |
| Cost of Revenue | UK£3.19m |
| Gross Profit | UK£2.81m |
| Other Expenses | UK£4.68m |
| Earnings | -UK£1.87m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Dec 04, 2024
| Earnings per share (EPS) | -0.02 |
| Gross Margin | 46.90% |
| Net Profit Margin | -31.10% |
| Debt/Equity Ratio | 0% |
How did PYPB perform over the long term?
See historical performance and comparison